These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8411970)

  • 21. [Electrophysiologic variants in late infantile neuronal-ceroid lipofuscinosis].
    Jović N
    Srp Arh Celok Lek; 1999; 127(11-12):407-11. PubMed ID: 10686824
    [No Abstract]   [Full Text] [Related]  

  • 22. Palmitoyl-protein thioesterase and the molecular pathogenesis of infantile neuronal ceroid lipofuscinosis.
    Hofmann SL; Lee LA; Lu JY; Verkruyse LA
    Neuropediatrics; 1997 Feb; 28(1):27-30. PubMed ID: 9151316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Juvenile neuronal ceroid lipofuscinosis].
    Santavuori P; Lappi M; Raitta C; Sainio K
    Duodecim; 1989; 105(3):273-9. PubMed ID: 2702939
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of neuronal ceroid-lipofuscinosis diagnosed by muscle biopsy].
    Matsuo M; Matsuzaka T; Orihara Y; Shimomura C; Tsuji Y; Nonaka M
    No To Hattatsu; 1990 Jul; 22(4):396-8. PubMed ID: 2400618
    [No Abstract]   [Full Text] [Related]  

  • 25. Avoid diagnostic delay of late infantile and juvenile neuronal ceroid-lipofuscinosis (LINCL, JNCL): a word to pediatricians, neurologists, and ophthalmologists.
    Heim P; Kohlschütter A
    Am J Med Genet; 1995 Jun; 57(2):238. PubMed ID: 7668337
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary sediment dolichols in the diagnosis of neuronal ceroid-lipofuscinosis.
    Wolfe LS; Palo J; Santavuori P; Andermann F; Andermann E; Jacob JC; Kolodny E
    Ann Neurol; 1986 Mar; 19(3):270-4. PubMed ID: 3963771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BATTEN DISEASE CAUSED BY A NOVEL MUTATION IN THE PPT1 GENE.
    Metelitsina TI; Waggoner DJ; Grassi MA
    Retin Cases Brief Rep; 2016; 10(3):211-3. PubMed ID: 26510000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Follow-up of Spielmeyer-Vogt disease over 21 years].
    Hoppen T; Ferrari R; Kohout B; Löhr-Nilles C; Rister M
    Klin Padiatr; 1992; 204(2):111-4. PubMed ID: 1583849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Juvenile neuronal-lipofuscinosis (Batten disease)].
    Mareque Rivas F
    Med Clin (Barc); 2008 Nov; 131(17):679. PubMed ID: 19087801
    [No Abstract]   [Full Text] [Related]  

  • 30. Juvenile neuronal ceroid lipofuscinosis and education.
    von Tetzchner S; Fosse P; Elmerskog B
    Biochim Biophys Acta; 2013 Nov; 1832(11):1894-905. PubMed ID: 23470553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Round-table discussion of animal models of ceroid-lipofuscinosis (Batten disease).
    Jolly RD
    J Inherit Metab Dis; 1993; 16(2):278-9. PubMed ID: 8411980
    [No Abstract]   [Full Text] [Related]  

  • 32. [Late infantile neuronal ceroid-lipofuscinosis: clinical symptoms and investigations].
    Kmieć T
    Pediatr Pol; 1995 Jun; 70(6):501-6. PubMed ID: 8692608
    [No Abstract]   [Full Text] [Related]  

  • 33. Gene table: neuronal ceroid lipofuscinoses.
    Mole S
    Eur J Paediatr Neurol; 2002; 6(2):129-30. PubMed ID: 11995961
    [No Abstract]   [Full Text] [Related]  

  • 34. Lymphocyte inclusions in Finnish-variant late infantile neuronal ceroid lipofuscinosis (CLN5).
    Rapola J; Lake BD
    Neuropediatrics; 2000 Feb; 31(1):33-4. PubMed ID: 10774993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juvenile neuronal ceroid lipofuscinoses (CLN3 Batten disease): what kind of epilepsy?
    Williams R
    Dev Med Child Neurol; 2015 Apr; 57(4):312. PubMed ID: 25523638
    [No Abstract]   [Full Text] [Related]  

  • 36. Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease): A Pilot Study of Feasibility and Reliability.
    Ragbeer SN; Augustine EF; Mink JW; Thatcher AR; Vierhile AE; Adams HR
    J Child Neurol; 2016 Mar; 31(4):481-7. PubMed ID: 26336202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Funding resources for rare disease research.
    Stehr F; Forkel M
    Biochim Biophys Acta; 2013 Nov; 1832(11):1910-2. PubMed ID: 23608548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuronal ceroid lipofuscinosis. An unknown overload disease].
    Echaniz-Laguna A; Tranchant C; Boehm N; Warter JM
    Presse Med; 1996 May; 25(18):853-6. PubMed ID: 8692764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redefining the "hyperphotoconvulsive" response of late-infantile neuronal ceroid lipofuscinosis.
    Talai A; Ng YT
    Pediatr Neurol; 2014 Feb; 50(2):195-6. PubMed ID: 24262339
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion).
    Järvelä I; Autti T; Lamminranta S; Aberg L; Raininko R; Santavuori P
    Ann Neurol; 1997 Nov; 42(5):799-802. PubMed ID: 9392580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.